These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8471725)

  • 1. Small angle neutron scattering studies of C8 and C9 and their interactions in solution.
    Esser AF; Thielens NM; Zaccai G
    Biophys J; 1993 Mar; 64(3):743-8. PubMed ID: 8471725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of terminal complement proteins in solution and modulation by suramin.
    Saez C; Thielens NM; Bjes ES; Esser AF
    Biochemistry; 1999 May; 38(21):6807-16. PubMed ID: 10346902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of the domain structure of C9 of human complement by neutron and X-ray solution scattering.
    Smith KF; Harrison RA; Perkins SJ
    Biochemistry; 1992 Jan; 31(3):754-64. PubMed ID: 1731932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The size, shape and stability of complement component C9.
    DiScipio RG
    Mol Immunol; 1993 Aug; 30(12):1097-106. PubMed ID: 8366860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
    Huang Y; Fedarovich A; Tomlinson S; Davies C
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution.
    Smith KF; Harrison RA; Perkins SJ
    Biochem J; 1990 Apr; 267(1):203-12. PubMed ID: 2327980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense sequences of 20-kDa homologous restriction factor (HRF20) are found in C9 and the C8 beta chain of homologous complement.
    Campbell W; Baranyi L; Okada N; Okada H
    Antisense Res Dev; 1993; 3(3):291-4. PubMed ID: 7506958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of the eighth and ninth components of carp complement.
    Uemura T; Yano T; Shiraishi H; Nakao M
    Mol Immunol; 1996 Aug; 33(11-12):925-32. PubMed ID: 8960116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the specific association of the eighth and ninth components of human complement: identification of a direct role for the alpha subunit of C8.
    Stewart JL; Sodetz JM
    Biochemistry; 1985 Aug; 24(17):4598-602. PubMed ID: 4063341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The shapes of biantennary and tri/tetraantennary alpha 1 acid glycoprotein by small-angle neutron and X-ray scattering.
    Perkins SJ; Kerckaert JP; Loucheux-Lefebvre MH
    Eur J Biochem; 1985 Mar; 147(3):525-31. PubMed ID: 3979385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-domain structure of the native and reactive centre cleaved forms of C1 inhibitor of human complement by neutron scattering.
    Perkins SJ; Smith KF; Amatayakul S; Ashford D; Rademacher TW; Dwek RA; Lachmann PJ; Harrison RA
    J Mol Biol; 1990 Aug; 214(3):751-63. PubMed ID: 2388266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conformation of the ribosomal protein S1 of Thermus thermophilus in solution under different ionic conditions].
    Timchenko AA; Shiriaev VM; Fedorova IuIu; Kihara K; Kimura K; Willumeit R; Garamus VM; Selivanova OM
    Biofizika; 2007; 52(2):216-22. PubMed ID: 17477047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis of the monomeric and dimeric C5b-9 complexes of complement: alteration in the susceptibility to proteases of the C9 subunits associated with C5b-9 dimerization.
    Yamamoto K; Migita S
    J Immunol; 1981 Aug; 127(2):423-6. PubMed ID: 7019323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.